Neoleukin Therapeutics Inc (NASDAQ:NLTX)
| 0.685 Delayed Data As of Sep 22 |  -0.014 / -2.00%Today’s Change | 0.38 Today|||52-Week Range 0.94 | +34.58% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | 25.0M | |
| Operating Expenses | Gross Income | 0.00 | 0.00 | 0.00 | -- | -- |
| General Expenses | 21.3M | 37.6M | 51.1M | 48.5M | ||
| Research And Development | 15.8M | 28.4M | 36.3M | 32.8M | ||
| Total Operating Expenses | 21.3M | 37.6M | 51.1M | 48.5M | ||
| Non-Operating Expenses | Operating Income | -21.3M | -37.6M | -51.1M | -23.5M | |
| Extraordinary Credit | 0.00 | 81.0K | 0.00 | 0.00 | ||
| Extraordinary Charge | -52.0K | 0.00 | 0.00 | -10.4M | ||
| Interest Expense On Debt | 99.0K | 1.0K | 4.0K | 4.0K | ||
| Other Expenses | -369.0K | -56.0K | -58.0K | 780.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -21.9M | -37.0M | -50.2M | -31.6M | |
| Net Income | -21.9M | -37.0M | -50.2M | -31.6M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 12.6M | 18.9M | 23.5M | 23.5M | |
| Shares To Calculate EPS Diluted | 12.6M | 18.9M | 23.5M | 23.5M | ||
| Earnings Per Share | EPS | -$1.73 | -$1.96 | -$2.14 | -$1.34 | |
| EPS Diluted | -$1.73 | -$1.96 | -$2.14 | -$1.34 | ||
